sglt2 inhibitors and glp 1 receptor agonists GLP-1 inhibitors: a couple at last? SGLT2 vs GLP-1 for CKD:

Metabolic endpoints (e.g., weight change, HOMA-IR, HbA1c) are most often supported by RCTs and therefore show relatively consistent and reproducible effects

More than weight loss, the drug has demonstrated ancillary advantages, including up to an 80% reduction in liver fat and alleviation of chronic knee pain and sleep apnea

[DOI] [PubMed] [Google Scholar] 54.Marso S.P., Daniels G.H., Brown-Frandsen K., Kristensen P., Mann J.F.E., Nauck M.A., Nissen S.E., Pocock S., Poulter N.R., Ravn L.S., et al

doi: 10.1152/ajpregu.00444.2015, 96 Matikainen-AnkneyB

These in-store curated displays, sponsored by Haleon, are designed to bring together pharmacist guidance and practical, easy-to-find products to make it simpler for patients to manage their treatment

Comfort-Boosting Tips for a Stress-Free GLP-1 Routine Staying on track with your therapy is easier when injections arent a source of dread